• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of pretransplant mutation status on survival after allogeneic stem cell transplant for acute myeloid leukemia.

作者信息

Selove William, Hutchinson Lloyd, Makarenko Vladislav, Meng Xiuling, Tomaszewicz Keith, Ramanathan Muthalagu, Cerny Jan, Nath Rajneesh, Chen Benjamin, Woda Bruce, Bledsoe Jacob R

机构信息

Department of Pathology UMass Memorial Medical Center University of Massachusetts Worcester Massachusetts USA.

Department of Hematology-Oncology UMass Memorial Medical Center University of Massachusetts Worcester Massachusetts USA.

出版信息

EJHaem. 2021 Jul 22;2(3):514-519. doi: 10.1002/jha2.260. eCollection 2021 Aug.

DOI:10.1002/jha2.260
PMID:35844698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9175694/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cd8/9175694/218e1faca65e/JHA2-2-514-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cd8/9175694/218e1faca65e/JHA2-2-514-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cd8/9175694/218e1faca65e/JHA2-2-514-g001.jpg

相似文献

1
Impact of pretransplant mutation status on survival after allogeneic stem cell transplant for acute myeloid leukemia.移植前突变状态对急性髓系白血病异基因干细胞移植后生存的影响。
EJHaem. 2021 Jul 22;2(3):514-519. doi: 10.1002/jha2.260. eCollection 2021 Aug.
2
DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.DNA 测序检测造血细胞移植前急性髓系白血病成人患者的残留疾病。
JAMA. 2023 Mar 7;329(9):745-755. doi: 10.1001/jama.2023.1363.
3
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.移植前NPM1微小残留病水平可预测急性髓系白血病患者异基因造血干细胞移植后的预后。
Blood Cancer J. 2016 Jul 29;6(7):e449. doi: 10.1038/bcj.2016.46.
4
Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplant.原因不明肺结节的急性髓系白血病患者接受异基因造血祖细胞移植的结果。
Eur J Haematol. 2016 Jan;96(1):55-9. doi: 10.1111/ejh.12547. Epub 2015 Apr 17.
5
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation.移植前 FLT3/ITD 状态可预测异基因造血干细胞移植后 FLT3 突变的急性髓系白血病的预后。
Ann Hematol. 2020 Aug;99(8):1845-1853. doi: 10.1007/s00277-020-04026-1. Epub 2020 Apr 24.
6
Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).11q23 异常的成人急性髓系白血病的异基因造血细胞移植：日本血液细胞移植学会（JSHCT）成人急性髓系白血病工作组的回顾性研究。
Ann Hematol. 2018 Nov;97(11):2173-2183. doi: 10.1007/s00277-018-3419-1. Epub 2018 Jul 6.
7
Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party.异基因造血干细胞移植治疗酪氨酸激酶抑制剂时代的慢性髓性白血病急变期：EBMT 慢性恶性肿瘤工作组的回顾性研究。
Biol Blood Marrow Transplant. 2019 Oct;25(10):2008-2016. doi: 10.1016/j.bbmt.2019.06.028. Epub 2019 Jul 1.
8
Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.缓解后强化化疗对首次完全缓解的急性髓系白血病患者行低强度预处理异基因造血干细胞移植后结局的影响：来自欧洲血液和骨髓移植学会急性白血病工作组的报告。
Cancer. 2014 Mar 15;120(6):855-63. doi: 10.1002/cncr.28498. Epub 2013 Dec 10.
9
Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR.移植前骨髓细胞和血细胞计数的恢复与 AML 患者在 CR 后接受异基因干细胞移植后的复发或生存风险无关。
Eur J Haematol. 2021 Sep;107(3):354-363. doi: 10.1111/ejh.13673. Epub 2021 Jun 14.
10
Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission.完全缓解的成人核心结合因子急性髓系白血病患者异基因移植时可测量残留病的预后价值
Bone Marrow Transplant. 2021 Nov;56(11):2779-2787. doi: 10.1038/s41409-021-01409-4. Epub 2021 Jul 16.

引用本文的文献

1
A molecular-based risk score for predicting leukemia-free survival in adult AML patients undergoing Allo-HSCT.一种基于分子的风险评分，用于预测接受异基因造血干细胞移植的成年急性髓系白血病患者的无白血病生存期。
iScience. 2025 Jul 7;28(8):113077. doi: 10.1016/j.isci.2025.113077. eCollection 2025 Aug 15.
2
Natural history of clonal haematopoiesis seen in real-world haematology settings.在现实血液学环境中观察到的克隆性造血的自然史。
Br J Haematol. 2024 May;204(5):1844-1855. doi: 10.1111/bjh.19423. Epub 2024 Mar 24.

本文引用的文献

1
Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with Positive Acute Myeloid Leukemia.异基因造血干细胞移植前微小残留病的分子检测预测成人急性髓系白血病阳性患者早期复发率高。
Cancers (Basel). 2019 Sep 28;11(10):1455. doi: 10.3390/cancers11101455.
2
How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?我们距离将可测量残留病纳入急性髓系白血病的临床实践还有多远？
Haematologica. 2019 Aug;104(8):1532-1541. doi: 10.3324/haematol.2018.208454. Epub 2019 Jul 4.
3
Next-generation sequencing-defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse.
下一代测序定义的干细胞移植前微小残留病可预测急性髓系白血病复发。
Am J Hematol. 2019 Aug;94(8):902-912. doi: 10.1002/ajh.25514. Epub 2019 Jun 14.
4
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.在 AML 患者进行异基因造血细胞移植前，通过 NGS 进行可测量残留病监测。
Blood. 2018 Oct 18;132(16):1703-1713. doi: 10.1182/blood-2018-02-829911. Epub 2018 Sep 6.
5
Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.基于数字液滴 PCR 的移植前 NPM1 突变负担绝对定量可预测急性髓系白血病患者的复发。
Ann Hematol. 2018 Oct;97(10):1757-1765. doi: 10.1007/s00277-018-3373-y. Epub 2018 May 22.
6
Molecular Minimal Residual Disease in Acute Myeloid Leukemia.急性髓系白血病的分子微小残留病。
N Engl J Med. 2018 Mar 29;378(13):1189-1199. doi: 10.1056/NEJMoa1716863.
7
Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation.多色流式细胞术和多基因下一代测序对异基因移植后急性髓系白血病复发具有互补性且预测性很强。
Biol Blood Marrow Transplant. 2017 Jul;23(7):1064-1071. doi: 10.1016/j.bbmt.2017.03.017. Epub 2017 Mar 15.
8
'CHIP'ping away at clonal hematopoiesis.逐步攻克克隆性造血
Leukemia. 2016 Aug;30(8):1633-5. doi: 10.1038/leu.2016.130. Epub 2016 Jun 17.
9
Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?急性髓系白血病：癌症克隆进化的范例？
Dis Model Mech. 2014 Aug;7(8):941-51. doi: 10.1242/dmm.015974.
10
Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission.人类急性髓系白血病中的白血病前期突变影响表观遗传调节剂，并在缓解期持续存在。
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2548-53. doi: 10.1073/pnas.1324297111. Epub 2014 Feb 3.